The estimated Net Worth of Larry J Strauss is at least $361 dollars as of 25 June 2004. Larry Strauss owns over 774 units of VIVUS stock worth over $361 and over the last 21 years Larry sold VVUS stock worth over $0.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Larry Strauss VVUS stock SEC Form 4 insiders trading
Larry has made over 1 trades of the VIVUS stock since 2004, according to the Form 4 filled with the SEC. Most recently Larry bought 774 units of VVUS stock worth $2,500 on 25 June 2004.
The largest trade Larry's ever made was buying 774 units of VIVUS stock on 25 June 2004 worth over $2,500. On average, Larry trades about 387 units every 0 days since 2003. As of 25 June 2004 Larry still owns at least 774 units of VIVUS stock.
You can see the complete history of Larry Strauss stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Larry Strauss's mailing address?
Larry's mailing address filed with the SEC is , , , , .
Insiders trading at VIVUS
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner, and Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
What does VIVUS do?
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
What does VIVUS's logo look like?
Complete history of Larry Strauss stock trades at VIVUS
VIVUS executives and stock owners
VIVUS executives and other stock owners filed with the SEC include:
-
John Amos,
Chief Executive Officer, Director -
John Slebir,
Senior Vice President - Business Development, General Counsel, Secretary -
Santosh Varghese,
Senior Vice President, Chief Medical Officer -
Mark Oki,
Chief Financial Officer, Senior Vice President, Chief Accounting Officer -
Thomas King,
Independent Director -
David Norton,
Independent Chairman of the Board -
Jill Frizzley,
Independent Director -
Herman Rosenman,
Independent Director -
Jorge Plutzky,
Independent Director -
Edward Kangas,
Independent Director -
Karen Ferrell,
Independent Director -
Allan Shaw,
Director -
Herm Rosenman,
Director -
Eric W Roberts,
Director -
Tide Capital, Llc North Tid...,
-
Seth H. Z. Fischer,
Chief Executive Officer -
Mayu Sris,
Director -
Kenneth Suh,
President -
Wesley Day,
Vice President, Clinical -
Michael /Ny/ Miller,
Chief Commercial Officer -
Wang Changjin,
VP, Business Development -
Virgil A Place,
Chairman & CSO -
Graham Strachan,
Director -
Samuel F Colin,
Director -
Ernest Mario,
Director -
Anthony P. Zook,
Chief Executive Officer -
John W Dietrich,
Vice President, R & D -
Terry Nida,
VP, Worldwide Marketing/ -
Svai S Sanford,
Interim CFO -
Mario M Rosati,
Director -
Alexander J Denner,
Director -
Jon C Biro,
10% owner -
J Martin Carroll,
Director -
Robert N Wilson,
Director -
Alexander J Sarissa Capital...,
-
M. Scott Oehrlein,
Chief Operations Officer -
Timothy E Morris,
VP, Finance and CFO -
Leland F Wilson,
President & CEO -
Linda M Dairiki Shortliffe,
Director -
Charles J Casamento,
Director -
Lee Perry,
Vice President & Chief -
Jacob Pieter Kastelein Joha...,
Director -
Michael J Astrue,
Director -
Mark B Logan,
Director -
Michael Patrick Miller,
SVP, Chief Commercial Officer -
Guy P Marsh,
VP, Operations & General Mgr. -
Neil Gesundheit,
VP, Chief Medical Officer -
Larry J Strauss,
Vice President, Finance & CFO -
James R Nickel,
Vice President, Clinical -
Peter Y Tam,
VP, Business Planning -
Carol Zoltowski,
Vice President, Regulatory -
Lori Forrest,
VP, Operations & General Mgr.